TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Electronic Cigarette Smoking on the Arterial Wall and Endothelial Glycocalyx Properties of Smokers
Brief Summary: Electronic cigarette is proposed as a bridge to smoking cessation. In this study we examine its effects on aortic elasticity, glycocalyx integrity, and exhaled carbon monoxide (CO) concentration and platelet function, both acutely and after 1 month of use.


Options:
A: Arm Label: Standard Arm (Arm A); Type: ACTIVE_COMPARATOR; Interventions: Other: TOBACCO CIGARETTES | Arm Label: Intervention Arm (Arm B); Type: ACTIVE_COMPARATOR; Interventions: Other: COMBUSTION-FREE NICOTINE DELIVERY SYSTEMS (C-F NDS) | Intervention Type: OTHER; Name: TOBACCO CIGARETTES; Assigned to Arm(s): Standard Arm (Arm A) | Intervention Type: OTHER; Name: COMBUSTION-FREE NICOTINE DELIVERY SYSTEMS (C-F NDS); Assigned to Arm(s): Intervention Arm (Arm B)
B: Arm Label: Electronic cigarette with or without nicotine; Type: ACTIVE_COMPARATOR; Interventions: Other: Electronic cigarette | Arm Label: Smoker control; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional cigarette | Intervention Type: OTHER; Name: Electronic cigarette; Assigned to Arm(s): Electronic cigarette with or without nicotine | Intervention Type: OTHER; Name: Conventional cigarette; Assigned to Arm(s): Smoker control
C: Arm Label: Electronic cigarettes; Type: EXPERIMENTAL; Interventions: Other: disposable electronic cigarettes | Intervention Type: OTHER; Name: disposable electronic cigarettes; Assigned to Arm(s): Electronic cigarettes
D: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: Brief Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Brief Intervention | Arm Label: Extended Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Extended Treatment | Intervention Type: BEHAVIORAL; Name: Brief Intervention; Assigned to Arm(s): Brief Treatment | Intervention Type: BEHAVIORAL; Name: Extended Treatment; Assigned to Arm(s): Extended Treatment | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Electronic Cigarette Smoking on the Arterial Wall and Endothelial Glycocalyx Properties of Smokers
Brief Summary: Electronic cigarette is proposed as a bridge to smoking cessation. In this study we examine its effects on aortic elasticity, glycocalyx integrity, and exhaled carbon monoxide (CO) concentration and platelet function, both acutely and after 1 month of use.


Options:
A: Arm Label: Ecig 24 mg nicotine; Type: EXPERIMENTAL; Interventions: Device: Ecig 24 mg nicotine | Arm Label: Ecig 0 mg nicotine; Type: SHAM_COMPARATOR; Interventions: Device: Ecig 0 mg nicotine | Arm Label: Nicotine free inhalator; Type: PLACEBO_COMPARATOR; Interventions: Device: Nicotine free inhalator | Intervention Type: DEVICE; Name: Ecig 24 mg nicotine; Assigned to Arm(s): Ecig 24 mg nicotine | Intervention Type: DEVICE; Name: Ecig 0 mg nicotine; Assigned to Arm(s): Ecig 0 mg nicotine | Intervention Type: DEVICE; Name: Nicotine free inhalator; Assigned to Arm(s): Nicotine free inhalator
B: Arm Label: Patch; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patch, Behavioral: Behavioural support | Arm Label: Patch and nicotine-free e-cigarette; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patch, Device: e-cigarette, Behavioral: Behavioural support | Arm Label: Patch and nicotine e-cigarette; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patch, Device: e-cigarette, Drug: Nicotine, Behavioral: Behavioural support | Intervention Type: DRUG; Name: Nicotine patch; Assigned to Arm(s): Patch, Patch and nicotine e-cigarette, Patch and nicotine-free e-cigarette | Intervention Type: DEVICE; Name: e-cigarette; Assigned to Arm(s): Patch and nicotine e-cigarette, Patch and nicotine-free e-cigarette | Intervention Type: DRUG; Name: Nicotine; Assigned to Arm(s): Patch and nicotine e-cigarette | Intervention Type: BEHAVIORAL; Name: Behavioural support; Assigned to Arm(s): Patch, Patch and nicotine e-cigarette, Patch and nicotine-free e-cigarette
C: Arm Label: Electronic cigarette with or without nicotine; Type: ACTIVE_COMPARATOR; Interventions: Other: Electronic cigarette | Arm Label: Smoker control; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional cigarette | Intervention Type: OTHER; Name: Electronic cigarette; Assigned to Arm(s): Electronic cigarette with or without nicotine | Intervention Type: OTHER; Name: Conventional cigarette; Assigned to Arm(s): Smoker control
D: Arm Label: IQOS; Type: EXPERIMENTAL; Interventions: Device: IQOS | Arm Label: E-CIG; Type: ACTIVE_COMPARATOR; Interventions: Device: E-CIG | Intervention Type: DEVICE; Name: IQOS; Assigned to Arm(s): IQOS | Intervention Type: DEVICE; Name: E-CIG; Assigned to Arm(s): E-CIG

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Electronic Cigarette Smoking on the Arterial Wall and Endothelial Glycocalyx Properties of Smokers
Brief Summary: Electronic cigarette is proposed as a bridge to smoking cessation. In this study we examine its effects on aortic elasticity, glycocalyx integrity, and exhaled carbon monoxide (CO) concentration and platelet function, both acutely and after 1 month of use.


Options:
A: Arm Label: Ecig group 1; Type: N/A; Interventions: N/A | Arm Label: Ecig group 2; Type: N/A; Interventions: N/A
B: Arm Label: Electronic cigarettes; Type: EXPERIMENTAL; Interventions: Other: disposable electronic cigarettes | Intervention Type: OTHER; Name: disposable electronic cigarettes; Assigned to Arm(s): Electronic cigarettes
C: Arm Label: EGO/CE4, 9mg nicotine; Type: OTHER; Interventions: Device: EGO/CE4, 9mg nicotine | Intervention Type: DEVICE; Name: EGO/CE4, 9mg nicotine; Assigned to Arm(s): EGO/CE4, 9mg nicotine
D: Arm Label: Electronic cigarette with or without nicotine; Type: ACTIVE_COMPARATOR; Interventions: Other: Electronic cigarette | Arm Label: Smoker control; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional cigarette | Intervention Type: OTHER; Name: Electronic cigarette; Assigned to Arm(s): Electronic cigarette with or without nicotine | Intervention Type: OTHER; Name: Conventional cigarette; Assigned to Arm(s): Smoker control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Automated Closed-Loop Versus Restrictive Fluid Therapy in Abdominal Surgery: a Pilot Randomized Controlled Trial
Brief Summary: The aim of this study is to compare hemodynamic variables and outcome in patients undergoing laparoscopic and/or robotic elective abdominal surgery. Patients will receive either an automated closed-loop goal-directed fluid therapy (GDFT) guided by non-invasive flow monitoring or a restrictive fluid therapy of 4ml/kg/h.


Options:
A: Arm Label: Closed-loop GDFT; Type: EXPERIMENTAL; Interventions: Device: Closed-Loop GDFT | Arm Label: Restrictive fluid therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive Fluid Therapy | Intervention Type: DEVICE; Name: Closed-Loop GDFT; Assigned to Arm(s): Closed-loop GDFT | Intervention Type: OTHER; Name: Restrictive Fluid Therapy; Assigned to Arm(s): Restrictive fluid therapy
B: Arm Label: Goal directed fluid therapy using esophageal doppler monitor; Type: ACTIVE_COMPARATOR; Interventions: Device: Esophageal Doppler Monitor | Arm Label: Fluid therapy using standard management; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Esophageal Doppler Monitor; Assigned to Arm(s): Goal directed fluid therapy using esophageal doppler monitor
C: Arm Label: Individualized Goal Directed Therapy (iGDT); Type: EXPERIMENTAL; Interventions: Procedure: Individualized Goal Directed Therapy | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Control Group | Intervention Type: PROCEDURE; Name: Individualized Goal Directed Therapy; Assigned to Arm(s): Individualized Goal Directed Therapy (iGDT) | Intervention Type: PROCEDURE; Name: Control Group; Assigned to Arm(s): Control
D: Intervention Type: PROCEDURE; Name: fluid management based on arterial pulse pressure variation; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Interventions to Promote Healthy Eating and Physical Activity in Lebanese School Children Targeting Overweight and Obesity.
Brief Summary: Evaluate the feasibility and effectiveness of a multi-component school-based intervention to promote healthy eating and physical activity with school children ages 9 to 11 years in Lebanon.


Options:
A: Arm Label: Intervention group- Health-E-PALS; Type: EXPERIMENTAL; Interventions: Other: Health-E-PALS- | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Health-E-PALS-; Assigned to Arm(s): Intervention group- Health-E-PALS
B: Arm Label: MOVI-da 10! active breaks; Type: EXPERIMENTAL; Interventions: Behavioral: MOVI-da10! active breaks | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: MOVI-da10! integrated physical activity; Type: EXPERIMENTAL; Interventions: Behavioral: MOVI-da10! integrated physical activity | Intervention Type: BEHAVIORAL; Name: MOVI-da10! active breaks; Assigned to Arm(s): MOVI-da 10! active breaks | Intervention Type: BEHAVIORAL; Name: MOVI-da10! integrated physical activity; Assigned to Arm(s): MOVI-da10! integrated physical activity
C: Arm Label: A Healthy School Start Plus intervention; Type: EXPERIMENTAL; Interventions: Behavioral: A Healthy School Start Plus intervention | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: A Healthy School Start Plus intervention | Intervention Type: BEHAVIORAL; Name: A Healthy School Start Plus intervention; Assigned to Arm(s): A Healthy School Start Plus intervention, Control
D: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Implementation of standing desks | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Implementation of standing desks; Assigned to Arm(s): Intervention group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparative Study Between Nifedipine and Ritodrine as Maintenance Tocolytic Therapy in Preterm Labor: A Randomized Controlled Trial
Brief Summary: A randomized controlled double blinded study included 200 women with preterm contractions. After successful arrest of contractions women were randomized into 2 equal groups: GI women received nifedipine 20 mg tablets twice daily and GII women received Ritodrine 5 mg tablets every 6 hours. The primary outcome was gestational age at delivery and the secondary outcomes include episodes of recurrent preterm labor, mode of delivery, maternal side effects and neonatal outcome


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Nifedipine extended release | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Nifedipine extended release; Assigned to Arm(s): A
B: Arm Label: Nifedipine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine 20 Mg | Arm Label: Ritodrine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ritodrine Oral Tablet | Intervention Type: DRUG; Name: Nifedipine 20 Mg; Assigned to Arm(s): Nifedipine | Intervention Type: DRUG; Name: Ritodrine Oral Tablet; Assigned to Arm(s): Ritodrine
C: Arm Label: Magnesium sulphate; Type: EXPERIMENTAL; Interventions: Drug: Magnesium Sulfate | Arm Label: Ritodrine; Type: EXPERIMENTAL; Interventions: Drug: Ritodrine | Arm Label: Calcium channel blocker; Type: EXPERIMENTAL; Interventions: Drug: Calcium Channel Blockers | Intervention Type: DRUG; Name: Magnesium Sulfate; Assigned to Arm(s): Magnesium sulphate | Intervention Type: DRUG; Name: Ritodrine; Assigned to Arm(s): Ritodrine | Intervention Type: DRUG; Name: Calcium Channel Blockers; Assigned to Arm(s): Calcium channel blocker
D: Arm Label: Indomethacin group; Type: EXPERIMENTAL; Interventions: Drug: Indomethacin | Arm Label: Nifedipine group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): Indomethacin group | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Influence of Manual Fascial Manipulation on the Function of the Pelvic Floor in Pregnant Women
Brief Summary: Pregnancy and vaginal delivery are considered as the main risk factors for damage to the pelvic floor. There are various ways to measure the strength of the pelvic floor and to evaluate functional problems. Manual mobilization of the pelvic floor is a well-known treatment modality, however, ample knowledge exists on the efficacy of physiotherapy and exercise for improvement of pelvic floor function and strength. The aim of this study is to analyze the influence of pelvic floor fascial mobilization (PFFM) technique on the function and strength of the pelvic floor muscles as well as parameters presumed to be influenced by the strength of the pelvic floor in pregnant women.


Options:
A: Arm Label: G1; Type: EXPERIMENTAL; Interventions: Procedure: Pregnants for receive the physical therapy guide | Intervention Type: PROCEDURE; Name: Pregnants for receive the physical therapy guide; Assigned to Arm(s): G1
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: tolterodine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: bladder training | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: pelvic floor muscle training | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Procedure: pelvic floor rehabilitation | Intervention Type: PROCEDURE; Name: tolterodine; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: bladder training; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: pelvic floor muscle training; Assigned to Arm(s): 3 | Intervention Type: PROCEDURE; Name: pelvic floor rehabilitation; Assigned to Arm(s): 4
C: Arm Label: Study group - Treatment with PFFM; Type: EXPERIMENTAL; Interventions: Procedure: Pelvic floor fascial mobilization | Arm Label: Control group -; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Pelvic floor fascial mobilization; Assigned to Arm(s): Study group - Treatment with PFFM
D: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise group | Intervention Type: BEHAVIORAL; Name: Exercise group; Assigned to Arm(s): Exercise group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Pedometer-Based Walking Intervention on Functional Capacity and Neurohumoral Modulation in Patients With Chronic Heart Failure With Preserved Ejection Fraction: a Multicenter Randomized Controlled Trial
Brief Summary: A multicenter randomized controlled trial, with follow-up at 6 and 12 months. Physically inactive participants with chronic heart failure with preserved or mid-range ejection fraction will be randomly assigned to intervention or control arms.

The six-month intervention will consist of an individualized pedometer-based walking program with weekly step goals, monthly face-to-face sessions with the physician, and monthly telephone calls with the research nurse. The intervention will be based on effective behavioral principles (goal setting, self-monitoring, personalized feedback).

The primary outcome is the change in 6-minute walk distance at 6 months. Secondary outcomes include changes in serum biomarkers levels, pulmonary congestion assessed by ultrasound, average daily step count measured by accelerometry, anthropometric measures, symptoms of depression, health-related quality of life, self-efficacy, and MAGGIC Risk Score.


Options:
A: Arm Label: Tai Chi; Type: EXPERIMENTAL; Interventions: Behavioral: 12-week Tai Chi Program | Arm Label: Heart Health Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 12-week Education Program | Intervention Type: BEHAVIORAL; Name: 12-week Tai Chi Program; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: 12-week Education Program; Assigned to Arm(s): Heart Health Education
B: Arm Label: Walking intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Walking intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Walking intervention; Assigned to Arm(s): Walking intervention
C: Arm Label: Non coronary patients (NC); Type: N/A; Interventions: N/A | Arm Label: Coronary patients (C); Type: N/A; Interventions: N/A
D: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supervised Exercise Training Program | Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Supervised Exercise Training Program; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Pedometer-Based Walking Intervention on Functional Capacity and Neurohumoral Modulation in Patients With Chronic Heart Failure With Reduced Ejection Fraction: a Multicenter Randomized Controlled Trial
Brief Summary: A multicenter randomized controlled trial, with follow-up at 6 and 12 months. Physically inactive participants with chronic heart failure with reduced ejection fraction will be randomly assigned to intervention or control arms.

The six-month intervention will consist of an individualized pedometer-based walking program with weekly step goals, monthly face-to-face sessions with the physician, and monthly telephone calls with the research nurse. The intervention will be based on effective behavioral principles (goal setting, self-monitoring, personalized feedback).

The primary outcome is the change in 6-minute walk distance at 6 months. Secondary outcomes include changes in serum biomarkers levels, pulmonary congestion assessed by ultrasound, average daily step count measured by accelerometry, anthropometric measures, symptoms of depression, health-related quality of life, self-efficacy, and MAGGIC Risk Score.


Options:
A: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supervised Exercise Training Program | Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Supervised Exercise Training Program; Assigned to Arm(s): 2
B: Arm Label: Walking intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Walking intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Walking intervention; Assigned to Arm(s): Walking intervention
C: Arm Label: No intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: Active Comparator; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Rehabilitation intervention | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): No intervention | Intervention Type: BEHAVIORAL; Name: Rehabilitation intervention; Assigned to Arm(s): Active Comparator
D: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control | Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Corneal Collagen Crosslinking to Increase the Resistance of the Graft Used as a Support for the Boston Keratoprosthesis Type I Against Corneal Melting
Brief Summary: The purpose of this study is to demonstrate the safety and efficacy of the corneal collagen crosslinking with riboflavin and ultraviolet A in aim to increase the resistance of the graft used as a support for the Boston keratoprosthesis (KPro) type I against corneal melting (keratolysis or sterile necrosis).


Options:
A: Arm Label: Kpro with crosslinked graft-support; Type: EXPERIMENTAL; Interventions: Procedure: Crosslinking with riboflavin of the corneal graft-support | Arm Label: KPro with normal graft-support; Type: ACTIVE_COMPARATOR; Interventions: Procedure: De-epithelisation of the corneal graft support with instillation of riboflavin | Intervention Type: PROCEDURE; Name: Crosslinking with riboflavin of the corneal graft-support; Assigned to Arm(s): Kpro with crosslinked graft-support | Intervention Type: PROCEDURE; Name: De-epithelisation of the corneal graft support with instillation of riboflavin; Assigned to Arm(s): KPro with normal graft-support
B: Arm Label: Riboflavin drops every minute; Type: ACTIVE_COMPARATOR; Interventions: Drug: Riboflavin | Arm Label: Riboflavin drops every 2 minutes; Type: ACTIVE_COMPARATOR; Interventions: Drug: Riboflavin | Intervention Type: DRUG; Name: Riboflavin; Assigned to Arm(s): Riboflavin drops every 2 minutes | Intervention Type: DRUG; Name: Riboflavin; Assigned to Arm(s): Riboflavin drops every minute
C: Arm Label: Collagen crosslinking group; Type: EXPERIMENTAL; Interventions: Procedure: collagen crosslinking group, Drug: Topical anti-fungal therapy | Arm Label: standard medical therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Topical anti-fungal therapy | Intervention Type: PROCEDURE; Name: collagen crosslinking group; Assigned to Arm(s): Collagen crosslinking group | Intervention Type: DRUG; Name: Topical anti-fungal therapy; Assigned to Arm(s): Collagen crosslinking group, standard medical therapy
D: Arm Label: conventional treatment; Type: EXPERIMENTAL; Interventions: Drug: topical voriconazole / levofloxacin systemic itraconazole | Arm Label: conventional treatment +CXL; Type: ACTIVE_COMPARATOR; Interventions: Drug: topical voriconazole / levofloxacin systemic itraconazole, Radiation: CXL | Intervention Type: DRUG; Name: topical voriconazole / levofloxacin systemic itraconazole; Assigned to Arm(s): conventional treatment, conventional treatment +CXL | Intervention Type: RADIATION; Name: CXL; Assigned to Arm(s): conventional treatment +CXL

Answer: A